NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
35 hedge funds and large institutions have $31.1M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
Holders
35
Holding in Top 10
–
Calls
$32K
Puts
$93K
Top Buyers
1 | +$12.2M | |
2 | +$3.69M | |
3 | +$2.23M | |
4 |
U
UBS
Zurich,
Switzerland
|
+$908K |
5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$880K |